Cart (0 Items)
Your cart is currently empty.
View Products
Brand: ProteoGenix
Daratumumab Biosimilar – Anti-CD38 mAb – Research Grade
- Isotype:
- IgG1, kappa
$143.00
0% OFF + 143 loyalty points- In Stock
- Wide range of unique reagents
- Fast worldwide delivery
Daratumumab Biosimilar - Anti-CD38 mAb - Research Grade
SDS-PAGE for Daratumumab Biosimilar - Anti-CD38 mAb
Daratumumab Biosimilar - Anti-CD38 mAb, on SDS-PAGE under reducing and non-reducing conditions. The gel was stained overnight with Coomassie Blue. The purity of the antibody is greater than 95%.
Daratumumab Biosimilar - Anti-CD38 mAb binds to CD38 Recombinant Protein in Indirect ELISA Assay
Immobilized CD38 Recombinant Protein (cat. No.PX-P4081) at 0.5µg/mL (100µL/well) can bind to Daratumumab Biosimilar - Anti-CD38 mAb (cat. No.PX-TA1213) in indirect ELISA with Goat Anti-Human IgG secondary antibody coupled with HRP measured by OD450
- Rebecca J. Brownlie, Ruth Kennedy, Erica B. Wilson, Maja Milanovic, Claire F. Taylor, Dapeng Wang, John R. Davies, Heather Owston, Emma J. Adams, Sophie Stephenson, Rebecca Caeser, Benjamin E. Gewurz, Peter V. Giannoudis, Claudio Scuoppo, Dennis McGonagle, Daniel J. Hodson, Reuben M. Tooze, Gina M. Doody, Gordon Cook, David R. Westhead, Ulf Klein; Cytokine receptor IL27RA is an NF-κB–responsive gene involved in CD38 upregulation in multiple myeloma. Blood Adv 2023; 7 (15): 3874–3890. doi: https://doi.org/10.1182/bloodadvances.2022009044
Be the first to review “Daratumumab Biosimilar – Anti-CD38 mAb – Research Grade”
There are no reviews yet.